Hualan Biological Engineering Inc. (002007.SZ)
Makes blood products, vaccines, and biological medicines for hospitals and patients in China.
13.26+0.02%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago-20.3%
The outlook
Hualan Biological is trading near its 52-week lows with analyst coverage suggesting meaningful upside—the average price target sits roughly 36% above the current level. The stock shows mixed momentum against its moving averages, and the neutral overall score reflects a lack of clear directional conviction. The trailing P/E of 28.2 sits moderately elevated for a biotech name.
What’s behind the score
Price trendMixed vs its moving averages
52-week range23% of the way from its 52-week low to high
Price targetAvg target +36% vs current price
Analyst price target
~12-month · 6 analysts18.04average target+36.0% vs now
Now 13.26
Low 15.00High 22.05
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$24.21B
52-wk high
18.39
52-wk low
11.72
50-day avg
13.16
200-day avg
14.81
Trailing P/E
28.2